Highland Capital Management (Tennessee)’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8	Closed	-$9K	–	344
2016 Q3	$9K	Sell	8 -2	-20%	-$1.75K	﹤0.01%	329
2016 Q2	$8K	Hold	10	–	–	﹤0.01%	328
2016 Q1	$7K	Hold	10	–	–	﹤0.01%	304
2015 Q4	$10K	Sell	10 -2	-17%	-$2.64K	﹤0.01%	305
2015 Q3	$13K	Hold	12	–	–	﹤0.01%	472
2015 Q2	$25K	Hold	12	–	–	﹤0.01%	439
2015 Q1	$11K	Hold	12	–	–	﹤0.01%	146
2014 Q4	$12K	Buy	+12	New	+$10.7K	﹤0.01%	162
2013 Q4	–	Sell	-8	Closed	-$21K	–	132
2013 Q3	$21K	Hold	8	–	–	﹤0.01%	126
2013 Q2	$70K	Buy	+8	New	+$61.6K	0.02%	121

Other funds holding ONCT

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FHA

First Horizon Advisors Memphis, Tennessee $3.85B AUM 16.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

DAM

Delta Asset Management Memphis, Tennessee $1.16B AUM 11.51% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

KLI

Kelman-Lazarov Inc Memphis, Tennessee $763M AUM 17.15% 1-Year Est. Return

Highland Capital Management (Tennessee)'s ONCT Position: Q4 2016 in Review

Highland Capital Management (Tennessee) sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2016, closing a stake of 8 shares — an estimated $9K sold.

Highland Capital Management (Tennessee) first reported a position in ONCT in Q2 2013 and held it in 10 quarters. The position peaked at $70K in Q2 2013. 21 funds tracked by Wall St. Rank hold ONCT as of Q4 2016.

Highland Capital Management (Tennessee) reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Highland Capital Management (Tennessee) sold 8 Oncternal Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $9K.
Highland Capital Management (Tennessee) first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 10 quarters.
Highland Capital Management (Tennessee)'s Oncternal Therapeutics, Inc. Common Stock position peaked at $70K in Q2 2013.
21 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2016, filed 20 Jan 2017.